Association between Comorbidities and COVID-19 Mortality: a Cross-Sectional Study in a Community Health Center in Indonesia

Authors

  • Sutaip Sutaip Master of Epidemiology, Postgraduate School, Diponegoro University, Semarang
  • Dwi Sutiningsih Master of Epidemiology, Postgraduate School, Diponegoro University, Semarang
  • Mateus Sakundarno Adi Master of Epidemiology, Postgraduate School, Diponegoro University, Semarang
  • Sutra Diyana Master of Epidemiology, Postgraduate School, Diponegoro University, Semarang
  • Siti Rahayu Master of Epidemiology, Postgraduate School, Diponegoro University, Semarang
  • Nur Azizah Azzahra Master of Epidemiology, Postgraduate School, Diponegoro University, Semarang
  • Puti Andalusia Sarigando Banilai Master of Epidemiology, Postgraduate School, Diponegoro University, Semarang
  • Giyantolin Giyantolin Master of Epidemiology, Postgraduate School, Diponegoro University, Semarang http://orcid.org/0000-0002-8576-5066

DOI:

https://doi.org/10.15850/ijihs.v11n2.3216

Keywords:

Characteristics, Comorbidity, COVID-19, Risk Factors.

Abstract

Objective: To analyze the risk factors for mortality and comorbidity of COVID-19 patients in a public health center work area in Indonesia.

Methods: This was a cross-sectional observational analytic quantitative study using secondary data of 820 confirmed COVID-19 cases in Brebes Public Health Center work area during the period of June 2020–December 2021. Univariate and bivariate analyses were used to analyze the obtained data statistically with a p-value of <0.005 considered significant.

Results: Of the 820 confirmed COVID-19 patients, 85.1% recovered and 15.0% died. Analysis on the characteristics of these cases showed that 51.2% females and 48.8 %  males were included in this study, with 77.6% of them were <60 years old. No history of comorbidities was identified in 92.1% of the cases. In remaining cases with comorbidities, Diabetes Mellitus was recognized as the most prevalent (n=39, 4.8%).  Results of the Chi-Square test demonstrated that comorbidity status (p-value = 0.001), place of quarantine (p p=0.000 p>0.05), and diabetes (p=0.000, OR=2.87,  95% CI 19 1.24-0280) were significantly associated with mortality.

Conclusion: Comorbidity status, diabetes, and the place quarantine are risk factors for mortality among COVID-19 confirmed cases, especially in Brebes Public Health Center work area. Thus, it is important to increase knowledge about COVID-19 prevention and risks to prevent transmission among those with higher risks for mortality. Further studies on factors related to sustainable supports for COVID-19 patients are also necessary.

References

  1. Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. 2020;10(2):102–8. doi:10.1016/j.jpha.2020.03.001
  2. WHO. WHO COVID-19 Dashboard [Internet]. World Health Organization. 2022. Available from: https://covid19.who.int/
  3. BBC. Coronavirus confirmed as pandemic by World Health Organization - BBC News. 2020.
  4. Brebes District Health Office. COVID-19 Case Data. Brebes: Brebes District Health Office; 2022.
  5. Destylya D. Karakteristik Pasien Covid-19 Di Rumah SakitUmum Pusat Haji Adam Malik MedanSumatera Utara. 2021;
  6. COVID-19 incidence and mortality in non-dialysis chronic kidney disease patints., et al. COVID-19 incidence and mortality in non-dialysis chronic kidney disease patints. PLoS One. 2021;16(7):e0254525. Published 2021 Jul 9. doi:10.1371/journal.pone.0254525
  7. Johnson KD, Harris C, Cain JK, Hummer C, Goyal H, Perisetti A. Pulmonary and extra-pulmonary clinical manifestations of COVID-19. Front Med (Lausanne). 2020;7:526. doi:10.3389/fmed.2020.00526
  8. Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis. 2021;21(1). doi:10.1186/s12879-021-06536-3
  9. Djaharuddin I, Munawwarah S, Nurulita A, Ilyas M, Ahmad N. Comorbidities and mortality in COVID-19 patients. Gac Sanit. 2021;35(S2):S530–2. doi:10.1016/j.gaceta. 2021.10.085
  10. Ndera ML, Supriyatni N, Rahayu A. Faktor komorbid terhadap covid-19 di Puskesmas Kota Tahun 2020. J BIOSAINSTEK. 2021;3(2):1–9. doi: https://doi.org/10.52046/biosainstek.v3i2.723
  11. Radwan NM, Mahmoud NE, Alfaifi AH, Alabdulkareem KI. Comorbidities and severity of coronavirus disease 2019 patients. Saudi Med J. 2020;41(11):1165–74. doi:10.15537/smj.2020.11.25454
  12. Ssentongo P, Ssentongo AE, Heilbrunn ES, Ba DM, Chinchilli VM. Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis. PLoS One. 2020;15(8):e0238215. doi:10.1371/journal.pone.0238215
  13. Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020;17(9):543-558. doi:10.1038/s41569-020-0413-9
  14. N Lestari, I Burhannudin. Diabetes melitus sebagai faktor risiko keparahan dan kematian pasien covid-19: meta-analisis. Biomedika. 2021;13(1):83–94. doi: 10.23917/biomedika.v13i1.13544
  15. Galvão Tessaro FH, Ayala TS, Bella LM, Martins JO. Macrophages from a type 1 diabetes mouse model present dysregulated Pl3K/AKT, ERK 1/2 and SAPK/JNK levels. Immunobiology. 2020;225(2):151879. doi:10.1016/j.imbio. 2019.11.014
  16. Sugawara E, Nikaido H. Properties of AdeABC and AdeIJK efflux systems of Acinetobacter baumannii compared with those of the AcrAB-TolC system of Escherichia coli. Antimicrob Agents Chemother. 2014;58(12):7250–7. doi:10.1128/AAC.03728-14
  17. Rifiana AJ, Suharyanto T. Hubungan diabetes mellitus dan hipertensi dengan kejadian corona virus deases-19 (Covid-19) di Wisma Atlit Jakarta Tahun 2020. Univ Nas. 2020;19:1–15.
  18. Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531–8. doi:10.1007/s00392-020-01626-9
  19. Firdaus I, Sukmawan R, Anwar Santoso DAJ, Firman D, Akbar N. Panduan diagnosis dan tatalaksana penyakit kardiovaskular pada pandemi covid-19. In: Perhimpunan Dokter Spesialis Kardiovaskular Indonesia. 2020.
  20. Kisid K, Putri EBA. Kejadian Covid-19 berdasarkan karakteristik pengunjung Poli ISPA Puskesmas Perampuan Lombok Barat. J Penelit dan Kaji Ilm. 2021;7(2):169–75. doi: https://doi.org/10.33651/jpkik.v7i2.276
  21. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–81. doi:10.1016/S2213-2600(20)30079-5
  22. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259–60. doi:10.1038/s41569-020-0360-5
  23. Xiong TY, Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: Acute and long-term implications. Eur Heart J. 2020;41(19):1798–800. doi:10.1093/eurheartj/ehaa231
  24. Winugroho T, Imansyah M, Bangun E, Apriyadi RK, Hidayat A. Analisis pengaruh faktor demografi terhadap lama karantina pada perawat terpapar Covid-19 di Jawa Tengah. PENDIPA J Sci Educ. 2021;5(2):229–36. https://doi.org/10.33369/pendipa.5.2.229-236
  25. Wang D, Yin Y, Hu C, Liu X, Zhang X, Zhou S, et al. Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China. Crit Care. 2020;24(1):1–9. doi:10.1186/s13054-020-02895-6
  26. Centers for Disease Control and Prevention (CDC). Interim US Guidance for Risk Assessment and Public Health Management of Persons with Potential 2019 Novel Coronavirus (2019-nCoV) Exposure in Travel-associated or Community Settings. Centers Dis Control Prev. 2020;2019:1–8.
  27. Han Y, Yang H. The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID-19): A Chinese perspective. J Med Virol. 2020;92(6):639–44. doi:10.1002/jmv.25749
  28. Shen Y, Li C, Dong H, Wang Z, Martinez L, Sun Z, et al. Community outbreak investigation of SARS-CoV-2 transmission among bus riders in Eastern China. JAMA Intern Med. 2020;180(12):1665–71. doi:10.1001/jamainternmed.2020.5225

Downloads

Published

2023-09-30

Issue

Vol. 11 No. 2 (2023)

Section

Articles

License

Authors retain copyright and grant International Journal of Integrated Health Sciences right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to freely share and remix the work with an acknowledgement of the work's authorship and initial publication in International Journal of Integrated Health Sciences.